Michael A. Carducci, M.D.

Dr. Michael Carducci is an Associate Professor of Oncology and Urology at the Johns Hopkins Medical Institutions. He obtained his medical degree from Wayne State University School of Medicine and received his residency training in internal medicine at the University of Colorado Health Sciences Center. He came to Hopkins for fellowship training in medical oncology. Dr. Carducci seeks to develop and evaluate new therapies for patients with urologic malignancies, including differentiation or anti-progression therapies, new cytotoxic agents, anti-angiogenic agents, inhibitors of growth regulatory pathways, combination therapy strategies incorporating surgery or radiation therapy, and gene therapy. Dr. Carducci's research laboratory focuses on delineating prostate cancer specific, differentiation therapy induced molecular pathways. These molecular pathways may lead to a greater understanding of prostate cancer growth and development and provide new therapeutic targets for clinical testing.

Clinically, Dr. Carducci conducts Phase I and Phase II clinical trials for patients with prostate, renal, and bladder cancers. Through these clinical trials, efficacy of new agents as well as their safety and tolerability can be evaluated. Few anti-progression agents have been clinically tested so that these trials provide a unique opportunity to explore novel markers of drug bioactivity and to develop drug-specific clinical trial designs and strategies. In addition, Dr. Carducci has an academic and clinical interest in the issues behind and in improving the provision of palliative and end-of-life care.

Dr. Carducci can be contacted at the following address:

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
1M89 Bunting Blaustein Building
1650 Orleans Street
Baltimore, MD 21231
Tel: (410) 614-3977
Fax: (410) 614-9006
E-mail: carducci@jhmi.edu